看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。+ A( [6 i4 y* e$ M% t; a
- @' r, i7 Q @6 d( Q* j4 S
7 ~8 C- E. O/ a3 W BCurrently available feasibility data for possible combination strategies.
' p3 v* e$ {8 u @0 u0 a. o————————————————————————————————
& R0 R# ?. S: |# c2 ~Combination Feasibility according to preliminary data / m- V( a5 A* U6 X) m: Z
——————————————————————————————————/ | w3 P( T. S8 {+ g8 \! U
Bevacizumab + sorafenib Yes, reduced dose
) Y) H1 M' t ]* q7 pBevacizumab + sunitinib† No + [6 g+ G0 C# U; ?
Bevacizumab + temsirolimus Yes $ p7 u; H& g; K* g( ]6 A- M7 C
Bevacizumab + everolimus Yes
4 }9 p q# w2 [# sSorafenib + sunitinib ?
0 Q, k: s; G, n8 ^ v+ TSorafenib + temsirolimus Yes, reduced dose
+ \5 t$ P. ~0 J! V# _. Q% I1 C4 kSorafenib + everolimus Yes, reduced dose
& M( }1 c. @5 WSunitinib + temsirolimus† No 1 h9 _) g$ P( M
Sunitinib + everolimus ?
3 A9 O |1 V2 Q( K) oTemsirolimus + everolimus ?
% c% y4 P4 |" V$ v j' D————————————————————* c" w* h/ l/ Q+ F! n# p' M
†Led to US FDA warning.
, |3 M, l6 x1 u' l, D?: As yet unattempted combination.
. ^" i9 |% |0 M |